The present work involves the development of new organic crystalline nanomedicines, namely, co-nanocrystals (co-NCs), that combine a chemotherapeutic agent with an anti-inflammatory active pharmaceutical ingredient (API), both in their nanocrystalline forms. T... ...

请注册登录后继续浏览